日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Can 3D Exoscopy-Assisted Surgery Replace the Traditional Endoscopy in Septoplasty? Analysis of Our Two-Year Experience

3D外窥镜辅助手术能否取代传统内窥镜鼻中隔成形术？我们两年经验的分析

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm14155279
Catalfamo, Luciano; Calvo, Alessandro; Cicchiello, Samuele; La Fauci, Antonino; De Ponte, Francesco Saverio; Scozzaro, Calogero; De Rinaldis, Danilo
3D/类器官
发表日期：2025
文献求助 收藏

Financing the cultural and creative industries through crowdfunding: the role of national cultural dimensions and policies

通过众筹为文化创意产业融资：国家文化因素和政策的作用

期刊:Journal of Cultural Economics
影响因子:2
doi:10.1007/s10824-022-09452-9
Cicchiello, Antonella Francesca; Gallo, Serena; Monferrà, Stefano
发表日期：2023
文献求助 收藏

How to Treat HR+/HER2- Metastatic Breast Cancer Patients after CDK4/6 Inhibitors: An Unfinished Story

CDK4/6抑制剂治疗后HR+/HER2-转移性乳腺癌患者的治疗策略：一个未完待续的故事

期刊:Life-Basel
影响因子:3.4
doi:10.3390/life12030378
Cogliati, Viola; Capici, Serena; Pepe, Francesca Fulvia; di Mauro, Pierluigi; Riva, Francesca; Cicchiello, Federica; Maggioni, Claudia; Cordani, Nicoletta; Cerrito, Maria Grazia; Cazzaniga, Marina Elena
CDK4
肿瘤
HER2
肿瘤免疫
乳腺癌
发表日期：2022
文献求助 收藏

Immunomodulatory effects of metronomic vinorelbine (mVRL), with or without metronomic capecitabine (mCAPE), in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer (MBC) patients: final results of the exploratory phase 2 Victor-5 study

在激素受体阳性（HR+）/HER2阴性转移性乳腺癌（MBC）患者中，节拍式长春瑞滨（mVRL）联合或不联合节拍式卡培他滨（mCAPE）的免疫调节作用：探索性II期Victor-5研究的最终结果

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-022-10031-6
Pepe, F F; Cazzaniga, M E; Baroni, S; Riva, F; Cicchiello, F; Capici, S; Cogliati, V; Maggioni, C; Cordani, N; Cerrito, M G; Malandrin, S
肿瘤
HER2
肿瘤免疫
信号转导
乳腺癌
免疫/内分泌
发表日期：2022
文献求助 收藏

Maxillofacial Injuries in Padel Game

板式网球比赛中的颌面部损伤

期刊:Journal of Maxillofacial & Oral Surgery
影响因子:0.6
doi:10.1007/s12663-022-01725-2
Catalfamo, L M; Scozzaro, C; Cicchiello, S; Scozzaro, M P; Romeo, C; De Rinaldis, D; Saccà, S; Nava, C; Calvo, A; De Ponte, F S
发表日期：2022
文献求助 收藏

Comparison of tumor microenvironment in primary and paired metastatic ER+/HER2- breast cancers: results of a pilot study

原发性和配对转移性ER+/HER2-乳腺癌肿瘤微环境的比较：一项初步研究的结果

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-021-07960-z
Zeppellini, Annalisa; Galimberti, Stefania; Leone, Biagio Eugenio; Pacifico, Claudia; Riva, Francesca; Cicchiello, Federica; Capici, Serena; Maggioni, Claudia; Sala, Luca; Cazzaniga, Marina Elena
肿瘤
HER2
肿瘤免疫
乳腺癌
肿瘤微环境
发表日期：2021
文献求助 收藏

2309. Promoting Healthcare Worker (HCW) Use of Personal Protective Equipment in Pediatric Ambulatory Settings

2309. 促进医护人员在儿科门诊环境中正确使用个人防护装备

期刊:
影响因子:
doi:10.1007/s12070-022-03413-6
Catalfamo, Luciano; De Rinaldis, Danilo; Cicchiello, Samuele; Scozzaro, Calogero; Nava, Carla; De Ponte, Francesco Saverio; Amaratunga, Shenali Anne; Tayeb, Tara Hussein; Dusatkova, Petra; Elblova, Lenka; Pruhova, Stepanka; Lebl, Jan; Mitra, Souvik; McCord, Helen; El Azrak, Mohamed; Paes, Bosco; Odeniyi, Folasade; Hanley, Samantha; Gianchetti, Lauren; Sharova, Anna; Handy, Lori; Coffin, Susan E; Feemster, Kristen
发表日期：2018
文献求助 收藏

Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study

在晚期HER2阴性乳腺癌患者中，采用口服长春瑞滨（mVNR）和卡培他滨（mCAPE）进行节拍化疗：这是否是优化疾病控制的一种方法？VICTOR-2研究的最终结果

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-016-4009-3
Cazzaniga, M E; Cortesi, L; Ferzi, A; Scaltriti, L; Cicchiello, F; Ciccarese, M; Della Torre, S; Villa, F; Giordano, M; Verusio, C; Nicolini, M; Gambaro, A R; Zanlorenzi, L; Biraghi, E; Legramandi, L; Rulli, E
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2016
文献求助 收藏